0000899243-19-017861.txt : 20190621 0000899243-19-017861.hdr.sgml : 20190621 20190621200131 ACCESSION NUMBER: 0000899243-19-017861 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190620 FILED AS OF DATE: 20190621 DATE AS OF CHANGE: 20190621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOFFMAN STEPHEN J CENTRAL INDEX KEY: 0001190418 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36281 FILM NUMBER: 19913034 MAIL ADDRESS: STREET 1: C/O SKYLINE VENTURES STREET 2: 525 UNIVERSITY AVE., SUITE 1350 CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc CENTRAL INDEX KEY: 0001399529 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 BUSINESS PHONE: 617 621 8097 MAIL ADDRESS: STREET 1: 87 CAMBRIDGEPARK DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02140 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-06-20 0 0001399529 Dicerna Pharmaceuticals Inc DRNA 0001190418 HOFFMAN STEPHEN J C/O DICERNA PHARMACEUTICS, INC. 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 1 0 0 0 Director Stock Option (right to buy) 15.44 2019-06-20 4 A 0 25000 0.00 A 2029-06-20 Common Stock 25000 25000 D This option vests monthly over 12 months from June 20, 2019 ("Grant Date") in substantially equal monthly installments, provided that the option will vest in full on the Issuer's next regularly scheduled annual meeting of stockholders that occurs following the Grant Date, subject to the Reporting Person's continued service to the Issuer through each such date or, if earlier, such annual meeting. Exhibit 24 - Power of Attorney /s/ John B. Green, attorney-in-fact 2019-06-21 EX-24 2 attachment1.htm EX-24 DOCUMENT
                         LIMITED POWER OF ATTORNEY FOR
                       SECTION 16 REPORTING OBLIGATIONS

     Know all by these presents, that the undersigned hereby makes, constitutes
and appoints each of Douglas Fambrough and John B. Green, or either of them
acting individually, and with full power of substitution, the undersigned's true
and lawful attorney-in-fact to:

     (1)   prepare, execute in the undersigned's name and on the undersigned's
           behalf, and submit to the U.S. Securities and Exchange Commission
           (the "SEC") a Form ID, including amendments thereto, and any other
           documents necessary or appropriate to obtain codes and passwords
           enabling the undersigned to make electronic filings with the SEC of
           reports required by Section 16(a) of the Securities Exchange Act of
           1934 (the "Exchange Act") or any rule or regulation of the SEC;

     (2)   execute for and on behalf of the undersigned, in the undersigned's
           capacity as an officer and/or director of Dicerna Pharmaceuticals,
           Inc., a Delaware corporation (the "Company"), Forms 3, 4, and 5,
           including amendments thereto, in accordance with Section 16(a) of the
           Exchange Act and the rules and regulations thereunder;

     (3)   seek or obtain, as the undersigned's representative and on the
           undersigned's behalf, information on transactions in the Company's
           securities from any third party, including brokers, employee benefit
           plan administrators and trustees, and the undersigned hereby
           authorizes any such person to release any such information to the
           undersigned and approves and ratifies any such release of
           information;

     (4)   do and perform any and all acts for and on behalf of the undersigned
           which may be necessary or desirable to complete and execute any such
           Form 3, 4, or 5, complete and execute any amendment or amendments
           thereto, and timely file such form with the SEC and any stock
           exchange or similar authority; and

     (5)   take any other action of any type whatsoever in connection with the
           foregoing which, in the opinion of such attorney-in-fact, may be of
           benefit to, in the best interest of, or legally required by, the
           undersigned, it being understood that the documents executed by such
           attorney-in-fact on behalf of the undersigned pursuant to this Power
           of Attorney shall be in such form and shall contain such terms and
           conditions as such attorney-in-fact may approve in such attorney-in-
           fact's discretion.

     The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming nor
relieving, nor is the Company assuming nor relieving, any of the undersigned's
responsibilities to comply with Section 16 of the Exchange Act.  The undersigned
acknowledges that neither the Company nor the foregoing attorneys-in-fact assume
(i) any liability for the undersigned's responsibility to comply with the
requirement of the Exchange Act, (ii) any liability of the undersigned for any
failure to comply with such requirements,  or (iii) any obligation or liability
of the undersigned for profit disgorgement under Section 16(b) of the Exchange
Act.

     This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier (a) revoked by the undersigned in a signed writing delivered to
the foregoing attorneys-in-fact or (b)superseded by a new power of attorney
regarding the purposes outlined herein at a later date.

     IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 20th day of June, 2019.

                                 /s/  Stephen J. Hoffman
                                 --------------------------------
                                 Signature

                                 Stephen J. Hoffman
                                 --------------------------------
                                 Print Name